prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma


  1. 2014
  2. Ultsch, B., Damm, O., Beutels, P., Bilcke, J., Brüggenjürgen, B., Gerber-Grote, A. U., Greiner, W., Hanquet, G., Harder, T., Hutubessy, R., Jit, M., Knol, M., Kuhlmann, A., Von Kries, R., Levy-Bruhl, D., Perleth, M., Postma, M. J., Salo, H., Siebert, U., ... Postma, M. (2014). Methods for health economic evaluations of vaccines-results from an international expert-workshop. Value in Health, 17(7), 552.
  3. Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P. L., Nord, E., Persson, U., Postma, M. J., Richardson, J., Simoens, S., De Sola-Morales, O., Tolley, K., & Toumi, M. (2014). The evaluation of economic methods to assess the social value of medical interventions for ultra-rare disorders (URDs). Value in Health, 17(7), A324.
  4. Van Boven, J., Tommelein, E., Mehuys, E., Boussery, K., Vegter, S., Brusselle, G., Rutten-Van Mölken, M., & Postma, M. (2014). Therapietrouwbevordering COPD bespaart kosten. Pharmaceutisch Weekblad, 149(39), 20-21.
  5. Bergmeijer, T. O., Janssen, P. W. A., Asselbergs, F. W., Schipper, J. C., Van 'T Hof, A. W., Dewilde, W. J. M., Postma, M. J., De Boer, A., Deneer, V. H. M., & Ten Berg, J. M. (2014). A tailored antiplatelet strategy in STEMI patients based on CYP2C19 genotyping is feasible in daily practice-POPular Genetics study. European Heart Journal, 35, 191-192.
  6. Schlander, M., Garattini, S., Holm, S., Kolominsky-Rabas, P., Nord, E., Persson, U., Postma, M., Richardson, J., Simoens, S., De Solà Morales, O., Tolley, K., & Toumi, M. (2014). Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. Journal of Comparative Effectiveness Research, 3(4), 399-422.
  7. Bergmeijer, T. O., Janssen, P. W. A., Schipper, J. C., Qaderdan, K., Ishak, M., Ruitenbeek, R. S., Asselbergs, F. W., van 't Hof, A. W. J., Dewilde, W. J. M., Spanó, F., Herrman, J-P. R., Kelder, J. C., Postma, M. J., de Boer, A., Deneer, V. H. M., & ten Berg, J. M. (2014). CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American Heart Journal, 168(1), 16-22.e1.
  8. Pitman, J. P., Wilkinson, R. L., Basavaraju, S. V., Von Finckenstein, B. G., Smit Sibinga, C. T. H., Marfin, A., Postma, M. J., Mataranyika, M. N., & Tobias, J. L. (2014). Investments in blood safety improve the availability of blood to underserved areas in a sub-saharan african country. Vox Sanguinis, 107(Supplement S1 (57-248)), 70-71.
  9. Radke, P. W., Halvorsen, S., Jukema, J. W., Kolh, P., Annemans, L., Postma, M. J., Ardissino, D., Kristensen, S. D., Bassand, J-P., Collet, J-P., Morais, J., Tuñón, J., & Halcox, J. (2014). Networks for improving care in patients with acute coronary syndrome: A framework. Acute Cardiac Care, 16(2), 41-48.
  10. Van Hasselt, F. M., Oud, M. J. T., Krabbe, P. F. M., Postma, M. J., & Loonen, A. J. M. (2014). Improving somatic health of outpatients with severe mental illness. Schizophrenia Research, 153(Supplement 1), S186-S187.
  11. Moolenaar, L. M., Connolly, M., Huisman, B., Postma, M. J., Hompes, P. G. A., van der Veen, F., & Mol, B. W. J. (2014). Costs and benefits of individuals conceived after IVF: a net tax evaluation in The Netherlands. Reproductive Biomedicine Online, 28(2), 239-245.
  12. Postma, M., & Boersma, C. (2014). Farmaco-economie. In HJ. Out, P. van Meurs, & R. van Olden (Eds.), Handboek farmaceutische geneeskunde (Vol. Hoofdstuk 7, pp. 99-118). Bohn, Stafleu, Van Loghum.
Previous 1...3 4 5 6 7 8 9 10 ...15 Next

ID: 193217